This continuing medical education (CME) activity will utilize engaging delivery formats for the expert faculty to review and discuss the latest data and the implications of the data in patient management.
Launch Date: June 15, 2021
Release Date: June 15, 2021
Expiration Date: May 31, 2022
This activity is intended for hematologist and oncologist, physicians, physician assistants, nurses and nurse practitioners who specialize in hematologic malignancies, particularly in multiple myeloma.
Upon completion of this enduring material, participants should be able to:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Practice Point Communications. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Each module associated with this activity is worth AMA PRA Category 1 Credit™.
PHYSICIAN ASSITANTS, NURSE PRACTIONERS, NURSES AND OTHER HEALTHCARE PROFESSIONALS
Physician Assistants (AAPA), Nurse Practitioners (AANP), and Nurses (ANCC) can count ACCME activities certified for AMA PRA Category 1 Credit™ for professional credit reporting purposes. All healthcare professionals, other than physicians, should inquire with their respective certifying or licensing boards to confirm.
The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.
The University is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The University requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all relationships with ineligible companies within the last 24-months. All identified conflicts of interests are thoroughly vetted and mitigated according to the ACCME and University’s policy. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.
The faculty and planners reported the following financial relationships, or relationships to products or devices, they have with ineligible companies (commercial interests) related to the content of this CME activity.
The speakers and planning committee members listed below have stated they have no significant relationships to disclose.
Susan Tyler, Ph.D
Robert Ellis, MD
Dr. Nina Shah
Research Funding: Bluebird Bio, Celgene/BMS, Janssen, Nektar, Poseida, Sutro Biopharma, Teneobio
Advisory: Amgen, CareDx, GSK, Indapta Therapeutics, Karyopharm, Kite, Oncopeptides, Sanofi
Dr. Joseph Mikhael
Consultant: Amgen, BMS, GSK, Karyopharm, Sanofi, Takeda
The opinions expressed during this activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati and Practice Point Communications. The information is presented for the purpose of advancing the attendees’ professional development.
The University of Cincinnati and Practice Point Communications protect the privacy of personal and other information regarding participants and educational collaborators. The University of Cincinnati and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The University of Cincinnati and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without prior written permission.